For More Information
Interested in learning about how Linical Americas can impact your next study?Learn More
Join Our investigator Network
Interested in becoming part of the Linical Americas Investigator network?Learn More
April 29, 2022
Many of you know my passion for drug, device, and diagnostic development and my commitment to the patient experience and patient diversity to ensure efficacy and safety for everyone. With that said, I wanted to share my personal experience as I just returned from my first (but not last) trip to Japan where I met with colleagues from Japan, China, Taiwan, Korea, and Singapore. Working globally with biopharma companies over the years, I have met numerous talented people from many cultural backgrounds. I was particularly impressed with all of the Linical colleagues I met along my journey to Japan, both personally and professionally.
In today’s blog I thought I would share some notes from my experience, with input from my respective country representatives and overall statistics of what is happening throughout Asia. While, Linical is a global CRO, I am going to focus on key countries including Japan, China, Korea, Taiwan, and Singapore. Linical has a strong presence in these countries based on their local expertise, commitment to quality, and successful project delivery.
In 2022, the Asia clinical trial market is estimated reach over $4 Billion USD and by 2027 estimated to be $6.3 Billion USD. Between 2017 and 2025, the CAGR growth rate of Asia is 12%. In 2020, Asia has a 45.3% share of global clinical trial activity and is not only growing rapidly but is a highly sought-after area for key therapeutic areas like, Oncology, Neurology, Infectious Disease, Rare Disease and Metabolic.
Asia has the ICH and GCP trained personnel and necessary experience to conduct global trials. The quality is extremely good with oversight and robust regulations that support and promote successful EMEA and FDA submissions. My expert country heads at Linical have shared many benefits in outsourcing clinical trials to Asia including countries like Japan, China, Korea, Taiwan, and Singapore:
Executive Vice President, Commercial Operations - Linical Americas